Amgen Inc (AMGN) Stock Price, Quote & News

Company Profile

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of my...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 805 447 1000

Fax: 805 447 1010

Website: www.amgen.com

Address:

One Amgen Center Drive, Thousand Oaks, United States

HeyHeyBooBoo Aug. 25 at 1:42 PM

$AMGN Sexy Banana!

0 · Reply

Quantumup Aug. 25 at 11:57 AM

Cantor🏁Apnimed Inc. at Outperform-$60 $IXHL $AMGN MLYS LLY BofA🏁 $APMD Buy-$41 Here's what Cantor and BofA said in their initiation reports: https://x.com/Quantumup1/status/2092219571407114700?s=20

0 · Reply

DarkFlowSignals Aug. 25 at 1:21 AM

Flight-to-safety Monday. Chips led the tape lower, $VIX ticked up, and money left both sides of the market. The only groups catching real bids: metals, defensives, gold and Treasuries. Our live book rode it: $SLV $57.5C 9/18 +68% (peak +190%) $AMGN $395C 9/18 +129% (peak +134%) $SOXX $520P 9/11 +33% (peak +58%), the semis hedge working $FCX $75C 9/11 +18% (peak +36%) Took 0 new signals. We do not chase leadership calls that are being sold under a green surface, especially with core PCE and a mega-cap chip report both landing Wednesday. Patience wins this one.

0 · Reply

parcha Aug. 25 at 1:01 AM

Tuesday's stock stories: What’s likely to move the market in the next session $AMGN Amgen hits a new high The Dow Industrials component is up 15% so far in August. Amgen shares are up 31% in three months. https://www.cnbc.com/2026/08/24/tuesdays-big-stock-stories-whats-likely-to-move-the-market.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension

0 · Reply

MomoPLLC Aug. 24 at 6:33 PM

$AMGN quietly no to ATH

0 · Reply

Stocktwits52wHighs Aug. 24 at 6:31 PM

$AMGN printed a new 52-week high today

0 · Reply

1manfund Aug. 24 at 1:51 PM

I purchased some $AMGN and $BVS

0 · Reply

1manfund Aug. 24 at 1:42 PM

$MRK $AMGN $GILD Compared on valuation multiples

0 · Reply

Makingmillions192 Aug. 24 at 1:18 PM

$LEXX Holy shit this is massive. • Proprietary DehydraTECH 3.0 amycretin tablet formulation more than doubled absolute bioavailability compared to a leading industry study • Proprietary DehydraTECH 3.0 retatrutide tablet formulation increased drug absorption by as much as an astonishing 4,552% compared to the DehydraTECH 2.0 retatrutide tablet evaluated • Findings support Lexaria's expanding strategic partnering outreach activities by evidencing DehydraTECH benefits for oral delivery of next generation GLP-1 drugs $LLY $NVO $PFE $AMGN

0 · Reply

ISimplyHaveNoIdea Aug. 24 at 2:07 AM

$AMGN $DFNS $GUTS $PRZO not a scam, just badly financed which is why they’ll have to Rs to get through to market a great product. Once they’ve RSd and stonked the share price it’ll be worth a fortune for pennies on the dollar

0 · Reply

Expert explains why healthcare is a top-performing sector

ABBV AMGN BIIB GILD JNJ LLY MRK

Aug 4, 2026, 4:30 PM EDT - 20 days ago

Amgen Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 20 days ago

Amgen Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 20 days ago

Amgen Slides: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 20 days ago

Amgen Quarterly report: Q2 2026

Aug 4, 2026, 4:14 PM EDT - 20 days ago

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

AMGN

Aug 4, 2026, 4:04 PM EDT - 20 days ago

Amgen second-quarter sales rise 9%, profit tops Street view

AMGN

Aug 4, 2026, 4:01 PM EDT - 20 days ago

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

AMGN

Jul 31, 2026, 4:13 PM EDT - 24 days ago

Amgen discloses data breach, says patient information was stolen

AMGN

Jul 30, 2026, 4:01 PM EDT - 25 days ago

AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND

AMGN

Jul 28, 2026, 4:45 PM EDT - 27 days ago

AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS

AMGN

Jul 24, 2026, 9:45 AM EDT - 4 weeks ago

Amgen submits new data to challenge FDA's proposal to withdraw Tavneos

AMGN

Jul 21, 2026, 11:10 AM EDT - 4 weeks ago

Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill

AMGN

Jul 1, 2026, 4:47 PM EDT - 7 weeks ago

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

AMGN

Jun 29, 2026, 4:46 PM EDT - 2 months ago

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

AMGN

Jun 26, 2026, 8:26 AM EDT - 2 months ago

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

AMGN

Jun 26, 2026, 7:10 AM EDT - 2 months ago

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

AMGN

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

Jun 14, 2026, 8:01 PM EDT - 2 months ago

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

AMGN

Jun 13, 2026, 8:00 AM EDT - 2 months ago

Drugmakers race to find a place in the next wave of obesity drugs

AMGN NVO AZN LLY

Jun 11, 2026, 7:28 PM EDT - 2 months ago

Amgen taps research firm to reassess Tavneos data

AMGN

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO PFE

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Amgen Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 7, 2026, 4:45 PM EDT - 2 months ago

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

AMGN

Jun 4, 2026, 4:01 PM EDT - 2 months ago

AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

AMGN

Jun 4, 2026, 9:55 AM EDT - 2 months ago

Amgen Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 9:00 AM EDT - 2 months ago

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

AMGN

May 29, 2026, 4:01 PM EDT - 3 months ago

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

AMGN

May 27, 2026, 11:45 AM EDT - 3 months ago

This Boring Income Portfolio Strategy Could Unlock 300%+ Upside

AMGN V

May 27, 2026, 9:00 AM EDT - 3 months ago

Ember LifeSciences announces new strategic investments boosting Series A to $27M

AMGN

May 21, 2026, 6:24 AM EDT - 3 months ago

Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths

AMGN

May 19, 2026, 5:20 PM EDT - 3 months ago

Amgen says CFO Peter Griffith to retire, names Dittrich as successor

AMGN

May 19, 2026, 4:05 PM EDT - 3 months ago

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

AMGN

May 15, 2026, 4:16 PM EDT - 3 months ago

Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports

AMGN

May 15, 2026, 3:37 PM EDT - 3 months ago

Twenty people in Japan who took an Amgen rare immune-disease drug have died, according to the company that sells the medicine in Japan. U.S. drug regulators had asked Amgen to voluntarily withdraw the drug.

AMGN

May 13, 2026, 1:00 PM EDT - 3 months ago

Amgen Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 4:01 PM EDT - 3 months ago

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

AMGN

May 4, 2026, 9:42 AM EDT - 4 months ago

Amgen to invest additional $300 million to boost US manufacturing footprint

AMGN

May 4, 2026, 9:00 AM EDT - 4 months ago

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

AMGN

Apr 30, 2026, 4:30 PM EDT - 4 months ago

Amgen Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

Amgen Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

Amgen Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

Amgen Quarterly report: Q1 2026

Apr 30, 2026, 4:19 PM EDT - 4 months ago

Amgen Posts Higher First-Quarter Profit, Revenue

AMGN

Apr 30, 2026, 4:06 PM EDT - 4 months ago

Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug

AMGN

Apr 30, 2026, 4:01 PM EDT - 4 months ago

AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

AMGN

Apr 27, 2026, 9:04 PM EDT - 4 months ago

FDA proposes to withdraw Amgen's rare autoimmune disease drug

AMGN

Apr 27, 2026, 12:55 PM EDT - 4 months ago

Pharma bets a little-known cholesterol will underpin its next blockbuster heart drugs

AMGN NVS LLY

Apr 24, 2026, 4:01 PM EDT - 4 months ago

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

AMGN

Apr 22, 2026, 4:00 PM EDT - 4 months ago

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

AMGN

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Amgen Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Amgen Proxy statement: Proxy filing

Apr 10, 2026, 4:10 AM EDT - 4 months ago

Amgen's lung cancer drug tarlatamab wins China approval

AMGN

Apr 7, 2026, 2:54 PM EDT - 4 months ago

15 stocks to put on your list to buy when the market recovers

ADBE BMY CVS KNSL MS NVDA TGT

Apr 6, 2026, 12:10 PM EDT - 5 months ago

Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.

AMGN VRDN

Apr 6, 2026, 9:00 AM EDT - 5 months ago

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

AMGN

Apr 3, 2026, 11:08 AM EDT - 5 months ago

Swiss industry body says US tariffs on pharmaceuticals will harm patients

ABBV AMGN AZN BMY MRK NVO

Apr 2, 2026, 5:34 PM EDT - 5 months ago

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

AZN NVO ABBV AMGN BMY MRK

Apr 2, 2026, 5:33 PM EDT - 5 months ago

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

ABBV AMGN AZN BMY MRK NVO

Apr 2, 2026, 3:29 PM EDT - 5 months ago

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

AZN NVO ABBV AMGN BMY MRK

Apr 2, 2026, 2:59 PM EDT - 5 months ago

Global pharma companies that have publicly announced Trump drug pricing agreements

ABBV AMGN AZN BMY MRK

Apr 1, 2026, 7:30 AM EDT - 5 months ago

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

AMGN ZLAB

HeyHeyBooBoo Aug. 25 at 1:42 PM

$AMGN Sexy Banana!

0 · Reply

Quantumup Aug. 25 at 11:57 AM

0 · Reply

DarkFlowSignals Aug. 25 at 1:21 AM

0 · Reply

parcha Aug. 25 at 1:01 AM

0 · Reply

MomoPLLC Aug. 24 at 6:33 PM

$AMGN quietly no to ATH

0 · Reply

Stocktwits52wHighs Aug. 24 at 6:31 PM

$AMGN printed a new 52-week high today

0 · Reply

1manfund Aug. 24 at 1:51 PM

I purchased some $AMGN and $BVS

0 · Reply

1manfund Aug. 24 at 1:42 PM

$MRK $AMGN $GILD Compared on valuation multiples

0 · Reply

Makingmillions192 Aug. 24 at 1:18 PM

0 · Reply

ISimplyHaveNoIdea Aug. 24 at 2:07 AM

0 · Reply

FWTestLog Aug. 23 at 3:22 PM

$AMGN — UPDATE: SETUP EXPIRED Limit $365.98 · order expired Paper forward test · Public track record · Not investment advice Trading Floor · Follow @FWTestLog #stocks #trading #swingtrading #USMarkets #Healthcare

0 · Reply

JuggernautRaider Aug. 22 at 9:49 PM

$NVO $LLY $AMGN $ABBV GET READY FOR MORE PAIN 🤕

1 · Reply

JuggernautRaider Aug. 22 at 9:47 PM

$GUTS might be a scam like $PRZO or $DFNS or $AMGN long 🧐

1 · Reply

DarkFlowSignals Aug. 22 at 2:08 AM

$NOW $105C settled +222% at expiry today (peaked +254%) - the day's banked winner on the live signal book. $GOOGL $330C closed +50% ITM. The metals bid stayed hot with gold ripping: $SLV runner +82%, fresh copper leg $FCX +35%. Healthcare led the tape and $AMGN sits +112%. Chips softened into the close. Two calls that had been up triple digits round-tripped to zero and rode to expiry. Rotation into healthcare + metals, tech soft.

0 · Reply

clan Aug. 21 at 7:03 PM

$MNKD What if..... For the good of all Mannkind, and .... those with leprocy. $UTHR $AMGN $PFE

0 · Reply

cAntshaker Aug. 21 at 4:50 PM

$AMGN Wow

0 · Reply

IN0V8 Aug. 20 at 1:54 PM

$AMGN Buying Opportunity Piper Sandler raises target price to $457 from $427

0 · Reply

albiegf13 Aug. 20 at 2:46 AM

$IBRX $MRNA Is a well known outfit because they were heavily used during the COVID19 era... Therefore many amature retail traders already knew the name and what they were involved in... Remember during COVID $MRNA traded as high as $450.00 PS, after COVID they traded as low as $28.00 PS... People know Moderna it was a household name because of the COVID19 era... We here at $IBRX are barely known in the retail community, we are going to have to engage in a junior high type of popularity contest to achieve the same reaction from the retail community.... That's the primary reason why I've stated many times that we will need to make a deal with a Big Pharma player, and it appears to me that the best candidate for such an event would be $AMGN... GOOD LUCK AND GOODNIGHT TO ONE AND ALL...!

1 · Reply

DarkFlowSignals Aug. 20 at 2:02 AM

Hawkish Fed minutes flipped the afternoon defensive. Health care led the tape, gold and silver ripped, and chips got sold. Our signal book leaned right into it: $LLY $1255C fresh entry today, green from the open, the cleanest call in the health care rotation $AMGN $395C up over +110% $NOW $105C up over +200% into a strong close $SLV $57.5C +28% as metals ran, peaked far higher earlier $SOXX puts +14%, the chip hedge working as semis sold Riding the defensive winners, not chasing the crowded chip and crypto pops that ran on the surface but were being sold into. More tomorrow.

0 · Reply

mikesterz7 Aug. 20 at 12:19 AM

$AMGN $RGEN Argus raised Amgen’s target to $460 from $375 and maintained a ‘Buy’ rating, according to The Fly. Amgen’s Q2 revenue increased 10% from a year earlier to $10.1 billion, while earnings per share rose to $6.29.

0 · Reply

judgeyoung2 Aug. 19 at 6:49 PM

So many mega bios breaking out at once today $MRK $AMGN $VRTX $LLY. ABBV?

1 · Reply

StocktwitsNews Aug. 19 at 6:21 PM

These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains? $AMGN $RGEN https://stocktwits.com/news/equity/markets/amgn-rgen-stocks-hit-52-week-highs-today/cZYdYDVRJlm

0 · Reply

Market Cap	237.52B
Revenue (ttm)	36.75B
Net Income (ttm)	7.71B
EPS (ttm)	N/A
PE Ratio	19.39
Forward PE	18.92
Profit Margin	20.98%
Debt to Equity Ratio	4.90

Volume	2,463,400
Avg Vol	2,709,228
Day's Range	N/A - N/A
Shares Out	540.63M
Stochastic %K	94%
Beta	0.41
Analysts	Sell
Price Target	$396.10